Stay updated on Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial
Sign up to get notified when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.

Latest updates to the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedA recruitment-closed notice has been added, and new help sections such as 'How to Read a Study Record' and 'How to Join a Study' have been introduced to assist visitors.SummaryDifference0.5%

- Check16 days agoChange DetectedThe page revision was updated from v3.5.4 to v3.5.5, signaling a minor administrative update to the study record metadata. No substantive content, criteria, or results have changed.SummaryDifference0.1%

- Check38 days agoChange DetectedA new revision label, Revision: v3.5.4, was added to the page, replacing the previous revision tag. This indicates a software/identity update to the site rather than a change to the study content or data.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page’s footer revision/version indicator was updated from v3.5.2 to v3.5.3, reflecting a site software release rather than any change to the clinical trial record content.SummaryDifference0.1%

- Check67 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check95 days agoChange DetectedRevision tag updated to v3.5.0; the v3.4.3 tag has been removed.SummaryDifference0.1%

Stay in the know with updates to Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaptesed with Pembrolizumab in Colorectal and Pancreatic Clinical Trial page.